EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Post-ERCP pancreatitis after self-expanding metal stent placement in patients with pancreatic versus non-pancreatic malignant biliary obstruction

Jad AbiMansour iD, Bret T Petersen, Eric J Vargas Valls, Ryan Law, Samuel Han, Vinay Chandrasekhara

Therapeutic Advances in Gastrointestinal Endoscopy · 2026-06 · 19

DOI: 10.1177/26317745261458987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Gastrointestinal Endoscopy, online erschienen am 23.06.2026. Verfasst von Jad AbiMansour und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic College of Medicine and Science, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Self-expanding metal stents (SEMS) are recommended for the endoscopic palliation of distal malignant biliary obstruction (DMBO). Placement of SEMS during endoscopic retrograde cholangiopancreatography (ERCP) has been associated with an increased risk of post-ERCP pancreatitis (PEP).

Objectives

The aim of this study is to evaluate rates of PEP in patients who underwent SEMS placement for pancreatic versus non-pancreatic malignancy.

Design

Retrospective Cohort Study.

Methods

Patients who underwent SEMS placement for DMBO between June 2017 and May 2021 were identified retrospectively from a procedural billing database. PEP incidence was compared between pancreatic and non-pancreatic DMBO groups and multivariate logistic regression was performed to identify risk factors for PEP.

Results

A total of 488 individuals were identified, with 395 (80.9%) cases of DMBO due to pancreatic and 93 (19.1%) due to non-pancreatic malignancy. Stent types included 124 (25.4%) fully covered (FCSEMS) and 364 (74.6%) uncovered metal stents (UCSEMS). The overall rate of PEP in the cohort was 6.3% with no significant difference between pancreatic and non-pancreatic etiologies (6.1% vs 7.5%, p = 0.606). When adjusted for age

Schlagwörter

Stichwörter der Autor:innen

biliary obstructioncholangiopancreatographyendoscopic retrogradepancreatic neoplasmspancreatitis

Autor:innen und Institutionen

  • Mayo Clinic College of Medicine and Science, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: Jad AbiMansour

Zitieren

APA

AbiMansour, J., Petersen, B. T., Vargas Valls, E. J., Law, R., Han, S., & Chandrasekhara, V. (2026). Post-ERCP pancreatitis after self-expanding metal stent placement in patients with pancreatic versus non-pancreatic malignant biliary obstruction. Therapeutic Advances in Gastrointestinal Endoscopy, 19. https://doi.org/10.1177/26317745261458987

Vancouver

AbiMansour J, Petersen BT, Vargas Valls EJ, Law R, Han S, Chandrasekhara V. Post-ERCP pancreatitis after self-expanding metal stent placement in patients with pancreatic versus non-pancreatic malignant biliary obstruction. Therapeutic Advances in Gastrointestinal Endoscopy. 2026;19. doi:10.1177/26317745261458987

BibTeX
@article{AbiMansour2026,
  author = {AbiMansour, Jad and Petersen, Bret T and Vargas Valls, Eric J and Law, Ryan and Han, Samuel and Chandrasekhara, Vinay},
  title = {Post-ERCP pancreatitis after self-expanding metal stent placement in patients with pancreatic versus non-pancreatic malignant biliary obstruction},
  journal = {Therapeutic Advances in Gastrointestinal Endoscopy},
  year = {2026},
  volume = {19},
  doi = {10.1177/26317745261458987}
}
Kostenlos starten →